Basic Information
| LncRNA/CircRNA Name | XLOC_009167 |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | lung cancer |
| ICD-0-3 | C34 |
| Methods | qPCR |
| Sample | lung cancer tissues, cell lines (SPC-A1, LTEP-a2, A549, NCIH1299, BEAS-2B) |
| Expression Pattern | up-regulated |
| Function Description | LncRNA XLOC_009167 was screened as a candidate biomarker for lung cancer and was up-regulated in both lung cancer tissues and cell lines. the ROC showed lncRNA XLOC_009167 was a better diagnostic potential compared to the traditional biomarkers (CYFR21-1, NSE and CA72-4), and the circulating lncRNA XLOC_009167 was found to be stable in whole blood under different conditions. |
| Pubmed ID | 30025752 |
| Year | 2018 |
| Title | Circulating lncRNA XLOC_009167 Serves as a Diagnostic Biomarker to Predict Lung Cancer. |
External Links
| Links for XLOC_009167 | GenBank HGNC NONCODE |
| Links for lung cancer | OMIM COSMIC |